Survey on Medication Adherence to Direct Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation (NVAF)

Survey on Medication Adherence to Direct Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation (NVAF) - Survey on Medication Adherence to DOACs in NVAF

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034176

Enrollment

1000

Registered

2018-09-25

Start date

2018-09-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Valvular Atrial Fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who have received the same DOAC (Apixaban, Edoxaban, Dabigatran, Rivaroxaban) for 3 months or more when giving consent 2) Patients who are prescribed DOAC for 28 days or more or 99 days or less on date of the consent 3) Patients who provide written consents by themselves in response to the explanation of this study

Exclusion criteria

Exclusion criteria: 1)Patients who aged less than 20 years of age 2)Patients currently participating or scheduled to participate in intervention studies 3)Patients hospitalized or expected to be hospitalized during participation in the study 4)Patients with adjustment of quantity in the prescription due to unused drugs patients own 5)Patients whose prescription is divided in more than twice 6)Any patients who are deemed inappropriate by research director or co-investigators

Design outcomes

Primary

Measure	Time frame
1)Percentage of DOACs with correct dosing 2)Rate of non-adherent patients to DOACs 3)Exploration of factors influencing adherence	—

Countries

Japan

Contacts

Public Contactaccerise.Inc. Adherence Contact Office

accerise.Inc. CRO Div.

office_adherence@accerise.co.jp03-5577-3872

Outcome results